Piper Sandler Upgrades Neogen to Overweight, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 90.4%

Neg 0% Neu 0% Pos 90.4%

Piper Sandler analyst David Westenberg upgrades Neogen (NASDAQ:NEOG) from Neutral to Overweight and raises the price target from $13 to $14.